52125-0568 Ondansetron

Product NDC:

52125-0568

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 4.0

Unit: mg/1

Packages:

Code: 52125-0568-02

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (52125-568-02)

Effective Date: Sept. 20, 2013

Discontinued: Nov. 10, 2015

Code: 52125-0568-08

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 VIAL (52125-568-08)

Effective Date: June 24, 2013

Discontinued: June 24, 2014

Code: 52125-0568-10

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 VIAL (52125-568-10)

Effective Date: March 28, 2014

Discontinued: Nov. 4, 2015

Code: 52125-0568-50

Description: 40 TABLET, ORALLY DISINTEGRATING in 1 VIAL (52125-568-50)

Effective Date: Oct. 29, 2014

Discontinued: Oct. 29, 2015

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox